In this context, the robust mouse LTBI reactivation model presents a much needed alternative to study LTBI compared to logistically challenging NHP models, and provides an opportunity to thoroughly investigate the importance of CD4+ T cell-independent strategies for TB vaccination, which are likely to significantly contribute to the immune response elicited by a broadly protective vaccine. This evidence concerns the gene CD4 and tuberculosis.